January 7, 2026
Three things to know about prostate cancer
Prostate cancer is the most common cancer in men. Urologic oncologist Matt Nielsen, MD, MS, FACS, shares three things to know about prostate cancer.
Tag: Matthew Nielsen
March 13, 2025
North Carolina Health News: NC House bill would expand access to early screening for prostate cancer
August 31, 2024
AJMC: Using Active Surveillance to Spare Men From Unneeded Prostate Cancer Treatment
June 17, 2024
Nielsen selected for NAM Scholars in Diagnostic Excellence program
Matthew Nielsen, MD, MS, was selected by the National Academy of Medicine to participate in the 2024 class of the NAM Scholars in Diagnostic Excellence program.
April 10, 2023
Opening up about prostate cancer
Albert Brunson didn’t tell anyone but his wife when he was diagnosed with prostate cancer. But a neighbor's death from metastatic prostate cancer changed his mind about sharing his story.
August 30, 2021
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.
July 27, 2021
Patients with advanced bladder cancer could benefit from immunotherapy regardless of gene mutation status
Led by William Kim, MD, and colleagues, this research has important implications for patients who have not been offered immunotherapy because of their genetic profiles.
August 13, 2019
Nielsen published in JAMA Internal Medicine
UNC Lineberger’s Matthew Nielsen, MD, MS, associate professor in the UNC School of Medicine Department of Urology, was the corresponding author of a paper published in JAMA Internal Medicine that assessed five different guidelines for evaluating blood in the urine. Nielsen and his co-authors, including UNC Lineberger’s Stephanie Wheeler, PhD, MPH, and Mihaela Georgieva, PhD, …